Elevated serum uric acid levels showed significant relationships with all-cause and cardiovascular death, but not cancer death.
Your search for cardiovascular disease returned 979 results
Active Filters
Click on a filter below to refine your search. Remove a filter to broaden your search.
Investigators compare multimorbidity profiles in patients with and without psoriasis.
Investigators explored the association between changes in smoking behavior and risk for cardiovascular disease incidence and mortality among patients with type 2 diabetes mellitus.
Investigators found a “dose-response” relationship between the level of residual kidney function and survival benefits.
A study was conducted to determine the relationship between a vegetarian diet and major cardiometabolic risk factors in patients at high risk for CVDs.
Findings seen regardless of whether hypertension persists in seated position
Investigators assessed how the outcomes of patients with psoriatic arthritis may be improved using lifestyle modifications and nonpharmacologic and psychological interventions.
Empagliflozin is a sodium-glucose co-transporter 2 inhibitor.
Even people with HIV that is well controlled with viral suppression are at increased risk for acute kidney injury.
Investigators assessed the risk for cardiovascular disease associated with DMARD use among patients with rheumatoid arthritis.
Benefit of ICD lower for cardiac resynchronization therapy recipients with advanced chronic kidney disease
Investigators assessed factors contributing to cardiovascular risk among patients with idiopathic inflammatory myopathies.
Researchers sought to investigate the associations of hospital-diagnosed infections and autoimmune diseases with the incidence of dementia and to examine the shared signals presented by the immune system in both conditions.
Growth differentiation factor-15 predicts major bleeding, major adverse cardiac events, and mortality in patients on hemodialysis.
A study was conducted to determine the cardiovascular effects of concomitant MRAs and SGLT2 inhibitors in patients with heart failure.
Highest age-adjusted mortality rates seen for Black individuals, and greatest temporal increase found in American Indian and Alaska Native individuals
Investigators explored correlations between the systemic immune-inflammation index (SII) scores and COPD.
Researchers developed a guide for clinicians to use ozanimod for the treatment of moderate to severe ulcerative colitis.
A study was conducted to determine the dose-response relationship between alcohol intake and blood pressure.
Investigators assessed the effects of inflammation and reduced cardiorespiratory fitness on all-cause mortality among patients with rheumatoid arthritis.
Estimates of use increased from 16.6 percent in low-income countries to 65.0 percent in high-income countries
Investigators assessed the safety and efficacy of Janus Kinase inhibitors for the treatment of rheumatoid arthritis.
Increasing quartiles of MEDLIFE index associated with reduced hazard ratios for all-cause, cancer mortality
Investigators assessed whether patients with antineutrophilic cytoplasmic antibody-associated vasculitis are at increased risk for cardiovascular disease during the months preceding their diagnosis.
Investigators assessed the prevalence of carotid plaque among patients with RA in the first 5 years since their diagnosis and evaluated disease characteristics associated with subclinical atherosclerosis.
In a prospective study, researchers investigated the impact of dental health on hippocampal volume in older adults.
Investigators assessed the effects of glucocorticoid dose and duration of treatment on the risk for major adverse cardiovascular events among patients with rheumatoid arthritis.
A study was conducted to determine the relationship between plasma factor XI and long-term cardiovascular outcomes in patients with type 2 diabetes.
Inorganic nitrate also reduced the risk for major adverse cardiac events in patients undergoing coronary angiography for non-ST-elevation acute coronary syndrome.
Semaglutide is a GLP-1 receptor agonist.
-
Latest News Your top articles for Wednesday
For More Personalized News -
Haymarket Medical NetworkTop Picks
- Loading...
Continuing Medical Education (CME/CE) Courses